News
Sanofi’s Foundation S & Sobi extend partnership with the World Federation of Haemophilia Humanitarian Aid Programme: Paris Saturday, April 26, 2025, 09:00 Hrs [IST] Sanofi, thro ...
Qure N.V. research and ratings by Barron's. View QURE revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.
Sanofi and Sobi have renewed their partnership with the World Federation of Hemophilia (WFH) to support the WFH Humanitarian Aid Program for up t ...
Financial report dates in 2026 Stora Enso Oyj will publish four interim reports in 2026. The publication dates for financial information will be as follows: Financial Statement release for 2025 4 ...
The Canadian Cancer Society (CCS) closed the 32nd edition of its prestigious Montreal Daffodil Ball by raising a historic amount of $3,413,908. Presented under the theme Prospective, the Ball ...
Up to five-year contract extension to support the WFH Humanitarian Aid Program with medicine donations and financial assistanceSTOCKHOLM, April 25, 2025 /PRNewswire/ -- Sobi® (STO: SOBI) together ...
Sobi® (STO: SOBI) together with the World Federation of Hemophilia (WFH) and Sanofi, through its philanthropic organisation Foundation S, announced the signing of a contract providing support to the ...
The World Federation of Hemophilia (WFH) and WFH USA, together with Sanofi, through its philanthropic organization Foundation ...
As Sanofi anticipates sales of immunotherapy juggernaut Dupixent reaching a major $22 billion by the end of the decade, ...
Sanofi (SNY) stock and Roche (RHHBY) stock trade flat after the duo reaffirmed 2025 forecasts despite strong Q1 results. Read ...
Sanofi confirms the expectation of a strong rebound in business EPS with growth at a low double-digit percentage at CER (before share buyback)6 • Sanofi intends to complete a share buyback program in ...
Business EPS was EUR 1.79, up 15.7% at CER and up 17.0% reported. Reports Q1 IRFS net sales EUR 9.9B, up 10.8% reported and up 9.7% at CER.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results